Measuring progress on NCDs: One goal and five targets

The Lancet

Volumn 380, Issue 9850, 2012, Pages 1283-1285

  Beaglehole, Robert ^a   Bonita, Ruth ^a   Horton, Richard ^b   Ezzati, Majid ^c   Bhala, Neeraj ^d   Amuyunzu Nyamongo, Mary ^e   Mwatsama, Modi ^f   Reddy, K Srinath ^g  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE LANCET   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e Consortium for NCD Prevention and Control in Sub Saharan Africa ^*  (Kenya)

^f National Heart Forum   (United Kingdom)

^g PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; SATURATED FATTY ACID; SODIUM;

ALCOHOL CONSUMPTION; ASTHMA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHILD HEALTH; CHILDHOOD OBESITY; CHRONIC RESPIRATORY TRACT DISEASE; DEVELOPING COUNTRY; DISEASE CONTROL; DISEASES; FAT INTAKE; GOAL ATTAINMENT; GOVERNMENT; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; IMMOBILIZATION; INCOME; MATERNAL WELFARE; MONITORING; MORTALITY; NONCOMMUNICABLE DISEASE; NOTE; POLICY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; SODIUM INTAKE; SODIUM RESTRICTION; WORLD HEALTH ORGANIZATION;

EID: 84867303366     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61692-4     Document Type: Note

References (20)

1. UN General Assembly. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. United Nations A/66/L.1. Sept 16, 2011. http://www.un.org/ga/search/view-doc. asp?symbol=A/66/L.1 (accessed June 23, 2012).
2. WHO. 65th World Health Assembly. WHA65(8) Prevention and control of noncommunicable diseases: follow-up to the High-level meeting of the United Nations General Assembly on the Prevention and Control of Noncommunicable diseases. June 5, 2012. http://apps.who.int/gb/ebwha/pdf-files/WHA65/A65-DIV3- en.pdf (accessed Oct 3, 2012).
3. WHO. Monitoring framework and targets for the prevention and control of NCDs. Revised WHO discussion paper on the development of a comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of NCDs. July 25, 2012. http://www.who.int/nmh/events/2012/ncd-discussion-paper/en (accessed Aug 12, 2012).
4. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet 2011; 377: 1438-47.
5. Beaglehole R, Ebrahim S, Reddy S, Voute J, Leeder S, on behalf of the Chronic Disease Action Group. Prevention of chronic diseases: a call to action. Lancet 2007; 370: 2152-57.
6. Mendez D, Alshanqeety O, Warner KE. The potential impact of smoking control policies on future global smoking trends. Tob Control 2012; published online April 25. DOI:10.1136/tobaccocontrol-2011-050147.
7. Abascal W, Esteves E, Goja B, et al. Tobacco control campaign in Uruguay: a population-based trend analysis. Lancet 2012; published online Sept 14. http://dx.doi.org/10.1016/S0140-6736(12)60826-5.
8. Smokefree 2025. http://smokefree.org.nz/smokefree-2025 (accessed June 23, 2012).
9. Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. Diet, nutrition and the prevention of chronic diseases. Geneva: World Health Organization, 2002.
10. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23: 363-84.
11. Sadler K, Nicholson S, Steer T, et al. National Diet and Nutrition Survey - assessment of dietary sodium in adults (aged 19 to 64 years) in England, 2011. A survey carried out on behalf of the Department of Health. https://www.wp.dh.gov.uk/transparency/files/2012/06/Sodium-Survey-England-2011- Text-to-DH-FINAL1.pdf (accessed Oct 2, 2012).
12. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011; 378: 1231-43.
13. Mehta S, Wells S, Grey C, et al. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort (PREDICT CVD-16). Euro J Prev Cardiol 2012; published online Oct 2. DOI:10.1177/2047487312462150.
14. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007; 70: 2044-53.
15. Lim SS, Gaziano TA, Gakidou E, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007; 370: 2054-62.
16. Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009; 373: 2234-46.
17. Zaridze D, Brennan P, Boreham J, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48 557 adult deaths. Lancet 2009; 373: 2201-14.
18. Malta DC, da Silva IB. Policies to promote physical activity in Brazil. Lancet 2012; 380: 195-96.
19. Leth T, Jensen HG, Mikkelsen AA, Bysted A. The effect of the regulation on trans fatty acid content in Danish food. Atheroscler Suppl 2006; 7: 53-56.
20. MacMahon S, Neal B, Rodgers A. Hypertension - time to move on. Lancet 2005; 365: 1108-09.